Literature DB >> 2648991

Significance of microflora in proteolysis in the colon.

S A Gibson1, C McFarlan, S Hay, G T MacFarlane.   

Abstract

Protease activities in human ileal effluent and feces were compared by using a variety of native and diazotized protein substrates. In many cases the diazotized proteins had altered susceptibilities to hydrolysis compared with the native proteins. Proteolytic activity was significantly greater than (P less than 0.001) in small intestinal effluent than in feces (319 +/- 45 and 11 +/- 6 mg of azocasein hydrolyzed per h per g, respectively). Moreover, fecal proteolysis was qualitatively different in that ileal effluent did not hydrolyze the highly globular protein bovine serum albumin, whereas all fecal samples tested degraded this substrate. Inhibition experiments provided further evidence that fecal protease activity differed from that in the small intestine. Physical disruption of fecal bacteria released large quantities of proteases, indicating that the lysis of bacteria in the colon may contribute to the extracellular proteolytic activity in feces. Protease inhibition studies with washed fecal bacteria showed that they produced serine, cystine, and metalloproteases, and experiments with synthetic p-nitroanilide substrates indicated that low levels of trypsin- and chymotrypsin-like activities were associated with whole cells. An elastase-like enzyme was bound to the outer membranes of some fecal bacteria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648991      PMCID: PMC184179          DOI: 10.1128/aem.55.3.679-683.1989

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  22 in total

1.  PROTEIN PRODUCING CAPACITY OF THE HUMAN EXOCRINE PANCREAS: INCORPORATION OF S35 METHIONINE IN SERUM AND PANCREATIC JUICE PROTEIN.

Authors:  J C KUKRAL; A P ADAMS; F W PRESTON
Journal:  Ann Surg       Date:  1965-07       Impact factor: 12.969

2.  Binding of trypsin and chymotrypsin by human intestinal mucosa.

Authors:  D M Goldberg; R Campbell; A D Roy
Journal:  Biochim Biophys Acta       Date:  1968-11-19

Review 3.  Cellulose and the human gut.

Authors:  J H Cummings
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

4.  Degradation of soluble and insoluble proteins by Bacteroides amylophilus protease and by rumen microorganisms.

Authors:  S Mahadevan; J D Erfle; F D Sauer
Journal:  J Anim Sci       Date:  1980-04       Impact factor: 3.159

Review 5.  Short chain fatty acids in the human colon.

Authors:  J H Cummings
Journal:  Gut       Date:  1981-09       Impact factor: 23.059

6.  Localization of proteinase(s) near the cell surface of Streptococcus lactis.

Authors:  T D Thomas; B D Jarvis; N A Skipper
Journal:  J Bacteriol       Date:  1974-05       Impact factor: 3.490

7.  The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine.

Authors:  J H Cummings; M J Hill; E S Bone; W J Branch; D J Jenkins
Journal:  Am J Clin Nutr       Date:  1979-10       Impact factor: 7.045

8.  Short chain fatty acid absorption by the human large intestine.

Authors:  N I McNeil; J H Cummings; W P James
Journal:  Gut       Date:  1978-09       Impact factor: 23.059

9.  Determination of immunoreactive trypsin, pancreatic elastase and chymotrypsin in extracts of human feces and ileostomy drainage.

Authors:  M Bohe; A Borgström; S Genell; K Ohlsson
Journal:  Digestion       Date:  1983       Impact factor: 3.216

10.  Studies of the extracellular proteolytic activity produced by Propionibacterium acnes.

Authors:  E Ingram; K T Holland; G Gowland; W J Cunliffe
Journal:  J Appl Bacteriol       Date:  1983-04
View more
  33 in total

1.  Changes in bacterial composition and enzymatic activity in ileostomy and ileal reservoir during intermittent occlusion: a study using dogs.

Authors:  J G Ruseler-van Embden; W R Schouten; L M van Lieshout; H J Auwerda
Journal:  Appl Environ Microbiol       Date:  1992-01       Impact factor: 4.792

2.  Physiological and nutritional factors affecting synthesis of extracellular metalloproteases by Clostridium bifermentans NCTC 2914.

Authors:  G T Macfarlane; S Macfarlane
Journal:  Appl Environ Microbiol       Date:  1992-04       Impact factor: 4.792

3.  Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Authors:  Rajkumar Malayandi; Phani Krishna Kondamudi; P K Ruby; Deepika Aggarwal
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

4.  Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.

Authors:  Shoko Edogawa; Adam L Edwinson; Stephanie A Peters; Lakshmikanth L Chikkamenahalli; Wendy Sundt; Sara Graves; Sakteesh V Gurunathan; Margaret Breen-Lyles; Stephen Johnson; Roy Dyer; Rondell Graham; Jun Chen; Purna Kashyap; Gianrico Farrugia; Madhusudan Grover
Journal:  Gut       Date:  2019-03-28       Impact factor: 23.059

5.  Luminal trypsin induces enteric nerve-mediated anion secretion in the mouse cecum.

Authors:  Osamu Ikehara; Hisayoshi Hayashi; Toshiharu Waguri; Izumi Kaji; Shin-ichiro Karaki; Atsukazu Kuwahara; Yuichi Suzuki
Journal:  J Physiol Sci       Date:  2014-01-14       Impact factor: 2.781

6.  May bacterial or pancreatic proteases play a critical role in inflammatory bowel disease?

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

7.  Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria.

Authors:  T Pessi; Y Sütas; M Saxelin; H Kallioinen; E Isolauri
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

Review 8.  Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.

Authors:  Ian M Carroll; Nitsan Maharshak
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

9.  Colonic absorption of insulin-like growth factor I in vitro.

Authors:  E Quadros; N M Landzert; S LeRoy; F Gasparini; G Worosila
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

Review 10.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.